Skip to main content

Table 4 Best Objective Response

From: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study

Response

# of Patients (%) (n = 90 evaluable)

95% C. I.

Complete

10 (11%)

5.5 – 19.5

Partial

18 (20%)

12.3 – 29.8

Complete/Partial

28 (31%)

21.8 – 41.7

Stable Disease

33 (37%)

26.8 – 47.5

Progressive Disease

29 (32%)

22.8 – 42.9